:: Library Catalog

Kapak Resmi

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Mamoor, Shahan
Materyal Türü:	Recurso digital
Dil:
Baskı/Yayın Bilgisi:	Zenodo 2025
Online Erişim:	https://doi.org/10.5281/zenodo.16968665
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

A comprehensive description of the circulating tumor cell: EXD3.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: PTPRU.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: ITGAD.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: TMEM25.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: HCAR1.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: GPRC5A.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A comprehensive description of the circulating tumor cell: TM6SF1.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: BUB1.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: GALNT6.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: KIF11.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: SKP2.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

MRPS31P5: Therapeutic targeting in colorectal cancer for the treatment of the primary tumor.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A relationship between p53 and Braf in mammalian cells.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

PAXX is activated in aging blood cells.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

An intrinsic link between the EMT program and aging in human cells.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

NLRP11 detects activation of CIDE cell death effectors.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Fam234b is selectively activated during the first cell division of the human embryo.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Pulmonary dendritic cells (CD11b(hi) CD14(hi) DC) are enriched for nestin.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: TM4SF4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Genes expressed in the CD4 + T lymphocyte.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

NLRC4 regulates a unique immunologic program.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Kinase targeting in Luminal A breast cancer: PIK3R1.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

TSC22D4 gene activation in Crohn's Disease.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PFKFB4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: LILRA4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PTPN4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: GRIK4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2026)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
Yazar:: Mamoor, Shahan
Baskı/Yayın Bilgisi: (2025)